Search
AstraZeneca PLC
AZNAdd to Watchlist
183.530USD
+2.510+1.39%
Market hours （ET）Quotes delayed by 15 min
569.30BMarket Cap
27.38P/E TTM
Revenue Breakdown
Currency: USDUpdated: Mon, Apr 6
Currency: USDUpdated: Mon, Apr 6
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
By BusinessUSD
Name
Revenue
Proportion
Farxiga
8.40B
15.12%
Tagrisso
7.25B
13.05%
Imfinzi
6.06B
10.91%
Ultomiris
4.72B
8.49%
Calquenc
3.52B
6.33%
Other
25.62B
46.10%
By RegionUSD
Name
Revenue
Proportion
United States
23.97B
43.13%
China
6.64B
11.94%
United Kingdom
4.36B
7.84%
Other European Countries
4.32B
7.77%
Japan
3.56B
6.40%
Other
12.73B
22.91%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Farxiga
8.40B
15.12%
Tagrisso
7.25B
13.05%
Imfinzi
6.06B
10.91%
Ultomiris
4.72B
8.49%
Calquenc
3.52B
6.33%
Other
25.62B
46.10%
